CLINICAL INFECTIOUS DISEASES, vol.69, no.11, pp.1969-1979, 2019 (SCI-Expanded)
Background. (Pegylated) Interferon ([Peg]IFN) therapy leads to response in a minority of chronic hepatitis B (CHB) patients. Host genetic determinants of response are therefore in demand.